Flood of corporate venturing units from different sectors join large healthcare companies in helping entrepreneurs develop their business as Global Corporate Venturing research reveals the top 75 most influential firms.

What links sugar company Tate & Lyle, oil major BP, a South Korean steel maker and General Electric, one of the world’s largest conglomerates?

They have all recently taken strategic stakes in healthcare and life sciences companies through their corporate venturing units and thereby created the potential for disruptive new businesses and technologies to emerge for the established pharmaceutical, biotechnology and medical technology and services groups.

BP’s decision to be the only strategic investor in Synthetic Genomics has…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?